Figure 1.

Study flow chart. Men were enrolled following referral for either an abnormal prostate specific antigen or digital rectal screening test and navigated through diagnostic resolution for patients without prostate cancer, treatment completion for those with prostate cancer, or end of study. Questionnaires were administered at baseline, within 3 months of diagnosis, and 3 months after treatment initiation to navigated subjects and a subsample of controls.

Nonzee et al. BMC Health Services Research 2012 12:340   doi:10.1186/1472-6963-12-340
Download authors' original image